Researcher says $25 version of Gilead drug could eradicate HIV in USA

For the past few months, CVS Caremark has declined to add a groundbreaking HIV prevention drug from Gilead Sciences to its formularies.

Clinical trials showed the twice-a-year injectable, called Yeztugo, was highly effective in preventing the…